These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1452519)

  • 1. Structure and mechanism of action of serpins.
    Gettins P; Patston PA; Schapira M
    Hematol Oncol Clin North Am; 1992 Dec; 6(6):1393-408. PubMed ID: 1452519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis.
    Izuhara Y; Takahashi S; Nangaku M; Takizawa S; Ishida H; Kurokawa K; van Ypersele de Strihou C; Hirayama N; Miyata T
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):672-7. PubMed ID: 18239154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do dysfunctional serpins tell us about molecular mobility and disease?
    Stein PE; Carrell RW
    Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Z/Z-dependent protease inhibitor (PZ/ZPI) anticoagulant system and thrombosis.
    Corral J; González-Conejero R; Hernández-Espinosa D; Vicente V
    Br J Haematol; 2007 Apr; 137(2):99-108. PubMed ID: 17391489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
    Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
    Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amplified mouse squamous cell carcinoma antigen gene locus contains a serpin (Serpinb3b) that inhibits both papain-like cysteine and trypsin-like serine proteinases.
    Askew DJ; Askew YS; Kato Y; Luke CJ; Pak SC; Brömme D; Silverman GA
    Genomics; 2004 Jul; 84(1):166-75. PubMed ID: 15203214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine protease inhibitors (serpins).
    Schapira M; Patston PA
    Trends Cardiovasc Med; 1991; 1(4):146-51. PubMed ID: 21239316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.
    Pike RN; Buckle AM; le Bonniec BF; Church FC
    FEBS J; 2005 Oct; 272(19):4842-51. PubMed ID: 16176258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor-2 is highly tolerant to P8 residue substitution--implications for serpin mechanistic model and prediction of nsSNP activities.
    Di Giusto DA; Sutherland AP; Jankova L; Harrop SJ; Curmi PM; King GC
    J Mol Biol; 2005 Nov; 353(5):1069-80. PubMed ID: 16214170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-D interhelical domain of the serpin plasminogen activator inhibitor-type 2 is required for protection from TNF-alpha induced apoptosis.
    Dickinson JL; Norris BJ; Jensen PH; Antalis TM
    Cell Death Differ; 1998 Feb; 5(2):163-71. PubMed ID: 10200461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular proteases and their inhibitors in genetic diseases of the central nervous system.
    Molinari F; Meskanaite V; Munnich A; Sonderegger P; Colleaux L
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R195-200. PubMed ID: 12925575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Lys335 in the metastability and function of inhibitory serpins.
    Im H; Yu MH
    Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpins: structure and mechanism of action.
    Travis J; Guzdek A; Potempa J; Watorek W
    Biol Chem Hoppe Seyler; 1990 May; 371 Suppl():3-11. PubMed ID: 2205240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.
    Weiss A; Joerss H; Brockmeyer J
    PLoS One; 2014; 9(10):e111363. PubMed ID: 25347319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors with conformational effects on haemostatic serpins: implications in thrombosis.
    Hernández-Espinosa D; Ordóñez A; Vicente V; Corral J
    Thromb Haemost; 2007 Sep; 98(3):557-63. PubMed ID: 17849043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and characterization of Manduca sexta serpin-6: a serine proteinase inhibitor that selectively inhibits prophenoloxidase-activating proteinase-3.
    Wang Y; Jiang H
    Insect Biochem Mol Biol; 2004 Apr; 34(4):387-95. PubMed ID: 15041022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.